Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.
Close

Ardena

Ardena is a leading CDMO providing early stage drug development and manufacturing for small-to-mid-sized biopharma.
Visit Website Read more
Invested
December 2019
Status
Current
Subsector
BioPharma
Corporate HQ
Ghent, Belgium

Ardena is a specialist CDMO and bioanalytical CRO dedicated to advancing precision medicines. Its integrated solutions enable innovative and complex molecules through services in nanomedicine, drug product and substance manufacturing, solid-state chemistry, bioanalytical services, and CMC regulatory support.

Ardena’s reputation for high science, quality and flexibility has drawn a client base of over 500 customers across Europe, the US, Japan and Korea. Ardena is headquartered in Belgium, operating seven sites across Belgium, The Netherlands, Sweden, Spain and the US.

Enablement & Alignment
Shared vision to create a global end-to-end CDMO, with niche capabilities

Core focus on nanomedicine and small molecule development and manufacturing catering small to mid-size biopharma.
Capability & Capacity
Further cross sell and upsell opportunities to be realized through Ardena’s fully integrated platform.

Significant opportunity to optimize the business development effort for a more integrated approach.

A number of inorganic growth avenues identified in specific adjacencies, including adding upstream capabilities to extend into discovery to take a molecule from target to clinic.
Building Strategic Footprints
Expanding footprint in the US and increasing sales team presence

Developing key partnerships across key Asian markets, supported by dedicated business developer for the region to drive regional growth outside of Europe
Corporate HQ Ghent, Belgium

Ardena News